Rabdomiólisis como presentación inicial de COVID-19. Caso Clínico
| Autor: | María Eugenia Sanhueza, Rubén Torres, Pedro Zamorano, Alondra Frías, Paula Almeida, Alfredo Parra-Lucares, Luis Toro, María Francisca Bozán, María Fernanda Silva |
|---|---|
| Jazyk: | Spanish; Castilian |
| Rok vydání: | 2021 |
| Předmět: |
myalgia
medicine.medical_specialty Gastroenterology Epigastric pain Rhabdomyolysis chemistry.chemical_compound Internal medicine medicine Renal Insufficiency Chronic Creatinine Lung biology business.industry SARS-CoV-2 COVID-19 General Medicine Acute Kidney Injury medicine.disease Pneumonia medicine.anatomical_structure chemistry biology.protein Ceftriaxone Creatine kinase medicine.symptom business medicine.drug |
| Zdroj: | Revista médica de Chile v.149 n.5 2021 SciELO Chile CONICYT Chile instacron:CONICYT |
| Popis: | COVID-19 infection causes a systemic inflammatory response, which mainly presents as a febrile syndrome with respiratory involvement. We report a 37-year-old male who consulted for myalgia, nausea and epigastric pain lasting three days. On admission, he had crepitations at the lung bases. The initial laboratory showed a creatine kinase of 62,768 U/L, a LDH of 1,110 IU/L, a creatinine a 2.1 mg/dL, an aspartate aminotransferase of 1,347 IU/L, a D-dimer of 1,140 ng/mL, a ferritin of 1,201 ng/mL and a lymphocyte count of 810 cells/mm3. The chest CT scan was compatible with multifocal pneumonia, suggesting a COVID-19 infection. COVID-19 PCR was positive. The patient was managed with hydration, sodium bicarbonate, ceftriaxone, and azithromycin, with a good clinical response. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|